Clinical Trial Update: Temozolomide Plus Radiation Therapy in Treating Patients With Newly Diagnosed Anaplastic Oligodendrogliomas or Mixed Anaplastic Oligoastrocytomas [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating temozolomide with radiation therapy in newly diagnosed anaplastic oligodendrogliomas or mixed anaplastic oligoastrocytomas.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anaplastic Oligodendroglioma
• Brain Tumors of the Central Nervous System
• Mixed Oligodendroglioma Astrocytoma

Drugs mentioned

• Temozolomide (Temozolomide)

Snippet

Sponsor: Radiation Therapy Oncology Group | Conditions: Brain and Central Nervous System Tumors | Phase 2 | Status: COMPLETED